Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Levy, Pierre L."'
Autor:
Lin, Chun-Pu, Levy, Pierre L., Alflen, Astrid, Apriamashvili, Georgi, Ligtenberg, Maarten A., Vredevoogd, David W., Bleijerveld, Onno B., Alkan, Ferhat, Malka, Yuval, Hoekman, Liesbeth, Markovits, Ettai, George, Austin, Traets, Joleen J.H., Krijgsman, Oscar, van Vliet, Alex, Poźniak, Joanna, Pulido-Vicuña, Carlos Ariel, de Bruijn, Beaunelle, van Hal-van Veen, Susan E., Boshuizen, Julia, van der Helm, Pim W., Díaz-Gómez, Judit, Warda, Hamdy, Behrens, Leonie M., Mardesic, Paula, Dehni, Bilal, Visser, Nils L., Marine, Jean-Christophe, Markel, Gal, Faller, William J., Altelaar, Maarten, Agami, Reuven, Besser, Michal J., Peeper, Daniel S.
Publikováno v:
In Cancer Cell 8 April 2024 42(4):623-645
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Blaising, Julie, Lévy, Pierre L., Polyak, Stephen J., Stanifer, Megan, Boulant, Steeve, Pécheur, Eve-Isabelle
Publikováno v:
In Antiviral Research October 2013 100(1):215-219
Autor:
Blaising, Julie, Levy, Pierre L., Gondeau, Claire, Phelip, Capucine, Varbanov, Mihayl, Teissier, Elodie, Ruggiero, Florence, Polyak, Stephen J., Oberlies, Nicholas H., Ivanovic, Tijana, Boulant, Steeve, Pécheur, Eve-Isabelle
Publikováno v:
Cellular Microbiology
Cellular Microbiology, Wiley, 2013, 15 (11), pp.1866-1882. ⟨10.1111/cmi.12155⟩
Cellular Microbiology, 2013, 15 (11), pp.1866-1882. ⟨10.1111/cmi.12155⟩
Cellular Microbiology, Wiley, 2013, 15 (11), pp.1866-1882. ⟨10.1111/cmi.12155⟩
Cellular Microbiology, 2013, 15 (11), pp.1866-1882. ⟨10.1111/cmi.12155⟩
International audience; Hepatitis C virus (HCV) is a global health concern infecting 170 million people worldwide. Previous studies indicate that the extract from milk thistle known as silymarin and its main component silibinin inhibit HCV infection.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::aaa7028700922ad072341277d5053874
https://hal.univ-lorraine.fr/hal-01494096
https://hal.univ-lorraine.fr/hal-01494096
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vredevoogd DW; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Apriamashvili G; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Levy PL; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Sinha S; Cancer Data Science Laboratory, National Cancer Institute Center for Cancer Research, Bethesda, Maryland, USA., Huinen ZR; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Visser NL; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., de Bruijn B; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Boshuizen J; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., van Hal-van Veen SE; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Ligtenberg MA; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Bleijerveld OB; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Lin CP; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Díaz-Gómez J; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Sánchez SD; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Markovits E; Ella Lemelbaum Institute for Immuno-oncology, Sheba Medical Center, Tel Hashomer, Israel.; Department of Clinical Microbiology and Immunology, Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel., Simon Nieto J; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., van Vliet A; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Krijgsman O; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands., Markel G; Department of Clinical Microbiology and Immunology, Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Davidoff Center and Samueli Integrative Cancer Pioneering Center, Rabin Medical Center, Petah Tikva, Israel., Besser MJ; Department of Clinical Microbiology and Immunology, Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Davidoff Center and Samueli Integrative Cancer Pioneering Center, Rabin Medical Center, Petah Tikva, Israel.; Felsenstein Medical Research Center, The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Altelaar M; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands.; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Ruppin E; Cancer Data Science Laboratory, National Cancer Institute Center for Cancer Research, Bethesda, Maryland, USA., Peeper DS; Department of Molecular oncology and immunology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands d.peeper@nki.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Nov 07; Vol. 12 (11). Date of Electronic Publication: 2024 Nov 07.